Avalo Therapeutics shares owned by Byrne Asset Management
Quarter-by-quarter ownership of Avalo Therapeutics shares owned by Byrne Asset Management
from 13F filings
Historical chart of Byrne Asset Management investment in Avalo Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Avalo Therapeutics held by Byrne Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Avalo Therapeutics by Byrne Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $89k | 4.8k | 18.48 |
Top funds holding Avalo Therapeutics
View all funds holding Avalo Therapeutics